Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content
Fig. 7 | Journal of Cannabis Research

Fig. 7

From: Evaluation of the metabolic activity, angiogenic impacts, and GSK-3β signaling of the synthetic cannabinoid MMB-2201 on human cerebral microvascular endothelial cells

Fig. 7

The synthetic cannabinoid MMB-2201 increased the release of VEGF, ANG-1, and ANG-2 from endothelial cells. VEGF, ANG-1, and ANG-2 release from HBEC-5i was investigated using ELISA. The release of these proteins was significantly increased at different concentrations of MMB-2201. Data are presented as mean ± SEM (n = 3). (*) indicates p < 0.05. (**) indicates p < 0.01. (***) indicates p < 0.001. (****) indicates p < 0.0001

Back to article page

Journal of Cannabis Research

ISSN: 2522-5782